Patent details

Basic Information

Publication number:

EP1199071

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP013088067

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Use of an estrogen agonist/antagonist for improving vascular health

French Title of Invention:

Utilisation d'un agoniste/antagoniste estrogénique pour améliorer la santé vasculaire

German Title of Invention:

Verwendung von Östrogen Agonist/Antagonist zur Verbesserung der vaskulären Gesundheit

SPC Number:

Dates

Filing date:

16/10/2001

Grant date:

24/05/2006

EP Publication Date:

24/05/2006

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/04/2002

EP B1 Publication Date:

24/05/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/10/2009

Expiration date:

16/10/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/10/2001

 

 

Name:

Pfizer Products Inc.

Address:

Eastern Point Road, Groton, Connecticut 06340, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

24/05/2006

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Lee Andrew G Pfizer Global Research & Development

Address:

United States (US)

2

Name:

Day Wesley W Pfizer Global Research & Development

Address:

United States (US)

3

Name:

Thompson D., Pfizer Global Research & Development

Address:

United States (US)

Priority

Priority Number:

241532 P

Priority Date:

17/10/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/40;

Filing date	Document type	Number of pages